- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- January 2025
- 305 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- May 2024
- 289 Pages
Global
From €3186EUR$3,500USD£2,706GBP
€4551EUR$5,000USD£3,865GBP
- Report
- July 2024
- 145 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- June 2024
- 310 Pages
Global
From €2230EUR$2,450USD£1,894GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 529 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 216 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- December 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- November 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- September 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- May 2024
- 226 Pages
Global
From €4414EUR$4,850USD£3,749GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more